Boat Welcomed to New Position as Dean

CINCINNATI—Thomas Boat, MD, was welcomed to his new role as the 50th dean of UC's College of Medicine during a morning reception on July 1, 2011.

The event, which included a light breakfast and gave faculty and staff a chance to greet and congratulate Boat, was held in the Dean's Suite of the UC CARE/Crawley building.

Boat previously served as executive associate dean for the College of Medicine since April 2008 and as chief executive officer of University of Cincinnati Physicians since July 2008.

To learn more about his plans and goals for the College of Medicine, click

here

.

Faculty and staff gathered on July 1, 2011, to welcome Thomas Boat, MD, in his new role as dean of the College of Medicine.

Faculty and staff gathered on July 1, 2011, to welcome Thomas Boat, MD, in his new role as dean of the College of Medicine.

Related Stories

1

Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December

December 12, 2025

This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.

2

Ohio nurses weigh in on proposed federal loan rule

December 12, 2025

Spectrum News journalist Javari Burnett spoke with UC Dean Alicia Ribar and UC nursing students Megan Romero and Nevaeh Haskins about proposed new federal student loan rules. Romero and Haskins, both seniors, were filmed in the College of Nursing’s Simulation Lab.

3

New combination treatment improves multiple myeloma outcomes

December 11, 2025

The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.